Harmony Biosciences surpassed $2 billion in cumulative net product revenue less than 5 years on the market, highlighting ...

In addition to sleep variability, concomitant opioid use and depressive symptoms influenced rates of fatigue in patients with ...

Both Epworth sleepiness scale (6.5 ± 4.0 vs 11.3 ± 3.9, respectively, p = 0.04) and fatigue (4.1 ± 2.1 vs 6.9 ± 2.0, respectively, p = 0.01) improved more with therapeutic devices than sham ...

A simple questionnaire, that can be completed in consultation with your GP, will place you on the Epworth Sleepiness Scale. This gives a measure of how likely you are to fall asleep during the day ...

Efficacy assessments will evaluate the effect of ORX750 on excessive daytime sleepiness (using the MWT and Epworth Sleepiness ...

Abnormal Involuntary Movement Scale; BDI: Beck Depression Inventory; DS: SCOPA–Sleep Daytime Sleepiness subscale; ESS: Epworth Sleepiness Scale; HADS–A: Hospital Anxiety and Depression Scale ...

The Epworth Sleepiness Scale (ESS) is often used to assess the severity of your daytime sleepiness and guide treatment decisions. The ESS asks you to rate your likelihood of dozing off or falling ...

If you don't, the trial ends. Epworth sleepiness scale. This simple questionnaire measures your level of daytime sleepiness. A typical question is something like: In your current, usual way of ...

Sleep disturbances, including snoring, are linked to diminished ovarian reserve in women, impacting fertility and hormone levels crucial for pregnancy.

Announced additional interim data from ongoing Phase 1 clinical study of ORX750, a novel orexin receptor 2 (OX2R) agonist, in ...

Cognition Therapeutics, Inc., (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical-stage company developing drugs that treat neurodegenerative disorders, presented participant baseline ...